Dove Medical Press Ltd
11
0
0
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
The Novel Electrolyzed Water Spray Treatment the Genital Itching
Role: lead
The Novel Electrolyzed Water Spray Treatment Mild Periodontitis
Role: lead
The Novel Electrolyzed Water Spray Treatment Mild Senile Groin Eczema, Neurodermatitis and Psoriasis
Role: lead
The Novel Electrolyzed Water Spray Treatment Discomfort, Redness and Swelling of the Skin Surrounding the Wound
Role: lead
Novel Electrolyzed Water Spray Treatment Mild Dermatophytosis
Role: lead
Local Injection of Periodontal Pocket Method for the Treatment of Gingivitis
Role: lead
A Novel Electrolyzed Water Spray Treatment for the Discomfort or Itching of Patients With Scalp
Role: lead
HA35 Treatment the Gingival Discomfort as Well as Gingival Redness and Bleeding of Patients With Periodontitis
Role: lead
Injection Therapy for Neuropathic Pain
Role: lead
The Research of Novel Electrolyzed Water Spray to Eradicate Bacteria E-coli and an Attenuated Human Flu Virus
Role: lead
A Clinical Study of Freshly Manufactured 35kDa Hyaluronan Fragment in the Treatment of Pain
Role: lead
All 11 trials loaded